| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
9.05 |
% |
10.6019/CHEMBL4513141 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
Inhibition |
5.34 |
% |
10.6019/CHEMBL4513141 |
| Canis lupus familiaris |
Brain |
Fu |
0.007 |
None |
10.1124/dmd.111.038778 |
| Cavia porcellus |
Cavia porcellus |
IC50 |
14.9 |
nM |
10.1021/jm960531r |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cavia porcellus |
Voltage-dependent L-type calcium channel subunit alpha-1C |
IC50 |
300.0 |
nM |
10.1002/jat.2784 |
| Cricetulus griseus |
CHO |
IC50 |
nan |
None |
10.1016/j.bmcl.2016.01.052 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-7.18 |
% |
10.6019/CHEMBL4513141 |
| Equus caballus |
Ferritin light chain |
Potency |
39810.7 |
nM |
None |
| Escherichia coli |
Escherichia coli |
Inhibition |
4.2 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli K-12 |
Endonuclease 4 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
10.1016/j.ejmech.2018.06.044 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
23099.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
8470.0 |
nM |
10.1021/jm9600205 |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
11577.4 |
nM |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
13700.0 |
nM |
10.1016/j.ejmech.2022.114346 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile acid receptor FXR |
Activity |
nan |
None |
10.1016/j.bmc.2013.04.069 |
| Homo sapiens |
Bile acid receptor FXR |
IC50 |
8960.0 |
nM |
10.1016/j.bmc.2013.04.069 |
| Homo sapiens |
Bile acid receptor FXR |
Inhibition |
67.5 |
% |
10.1016/j.bmc.2013.04.069 |
| Homo sapiens |
Bile acid receptor FXR |
Inhibition |
nan |
% |
10.1016/j.bmc.2013.04.069 |
| Homo sapiens |
Bile salt export pump |
AC50 |
4500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
10100.0 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bile salt export pump |
IC50 |
135000.0 |
nM |
10.1093/toxsci/kfq269 |
| Homo sapiens |
Bloom syndrome protein |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
nan |
None |
10.1016/j.ejmech.2018.06.044 |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
15743.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
1736.0 |
nM |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
1371.0 |
nM |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
477.5 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
7200.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
2170.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
4000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
1000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
1690.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
18300.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2J2 |
IC50 |
3380.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
1780.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
85.0 |
% |
10.1021/jm00159a007 |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Rate of oxidation |
0.55 |
None |
10.1021/jm00159a007 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA polymerase iota |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
3200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Geminin |
Potency |
1883.7 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
13335.9 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
8600.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glutamate [NMDA] receptor |
Inhibition |
nan |
% |
10.1016/j.ejmech.2018.11.051 |
| Homo sapiens |
HEK293 |
Potency |
5171.4 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
HERG |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-69.49 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
4.28 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
5972.8 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
Activity |
nan |
None |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
CL |
15.0 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.5b00201 |
| Homo sapiens |
Homo sapiens |
CL |
15.0 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
15.0 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.0 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.0 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Cmax |
195.0 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
F |
13.0 |
% |
10.1016/j.bmc.2007.08.060 |
| Homo sapiens |
Homo sapiens |
Fa |
0.9 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.12 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
0.38 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.35 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
T1/2 |
1.3 |
hr |
10.1021/acs.jmedchem.5b00201 |
| Homo sapiens |
Homo sapiens |
Vdss |
1.1 |
L.kg-1 |
10.1021/acs.jmedchem.5b00201 |
| Homo sapiens |
Homo sapiens |
Vdss |
1.1 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Vdss |
1.5 |
L.kg-1 |
10.1016/j.ejmech.2009.06.004 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Liver microsomes |
CL |
300.0 |
mL.min-1.g-1 |
10.1016/j.bmcl.2011.12.005 |
| Homo sapiens |
L-type calcium channel alpha-1c/beta-2/alpha2delta-1 |
IC50 |
29.8 |
nM |
10.1021/acs.jmedchem.2c00458 |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide S receptor |
Potency |
1584.9 |
nM |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Peripheral myelin protein 22 |
Potency |
75686.3 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 1C |
IC50 |
1243.0 |
nM |
10.1021/acs.jmedchem.2c00458 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
4800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
IC50 |
7150.0 |
nM |
10.1021/acs.jmedchem.2c00458 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
661.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
907.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
EC50 |
390.0 |
nM |
10.1016/j.bmc.2013.04.069 |
| Homo sapiens |
Pregnane X receptor |
max activation |
125.9 |
% |
10.1016/j.bmc.2013.04.069 |
| Homo sapiens |
Prelamin-A/C |
Potency |
1.8 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
4.5 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
532.3 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
SH-SY5Y |
Activity |
32.0 |
% |
10.1016/j.ejmech.2011.03.003 |
| Homo sapiens |
SH-SY5Y |
Activity |
35.9 |
% |
10.1016/j.bmc.2008.07.005 |
| Homo sapiens |
SH-SY5Y |
Activity |
35.9 |
% |
10.1016/j.ejmech.2007.06.001 |
| Homo sapiens |
SH-SY5Y |
Activity |
35.93 |
% |
10.1021/jm061047j |
| Homo sapiens |
SH-SY5Y |
Activity |
35.93 |
% |
10.1021/jm801292b |
| Homo sapiens |
SH-SY5Y |
Activity |
36.03 |
% |
10.1016/j.bmc.2008.07.005 |
| Homo sapiens |
SH-SY5Y |
Activity |
36.03 |
% |
10.1016/j.ejmech.2007.06.001 |
| Homo sapiens |
SH-SY5Y |
Activity |
36.03 |
% |
10.1021/jm061047j |
| Homo sapiens |
SH-SY5Y |
Activity |
36.03 |
% |
10.1021/jm801292b |
| Homo sapiens |
SH-SY5Y |
Activity |
45.5 |
% |
10.1016/j.ejmech.2007.06.001 |
| Homo sapiens |
SH-SY5Y |
Activity |
75.0 |
% |
10.1016/j.bmc.2008.07.005 |
| Homo sapiens |
SH-SY5Y |
Activity |
75.0 |
% |
10.1016/j.ejmech.2007.06.001 |
| Homo sapiens |
SH-SY5Y |
Activity |
75.0 |
% |
10.1021/jm061047j |
| Homo sapiens |
SH-SY5Y |
Activity |
75.4 |
% |
10.1016/j.ejmech.2007.06.001 |
| Homo sapiens |
SH-SY5Y |
Activity |
75.42 |
% |
10.1016/j.bmc.2008.07.005 |
| Homo sapiens |
SH-SY5Y |
Activity |
75.42 |
% |
10.1021/jm061047j |
| Homo sapiens |
SH-SY5Y |
Activity |
nan |
None |
10.1016/j.bmcl.2017.06.045 |
| Homo sapiens |
SH-SY5Y |
Inhibition |
45.5 |
% |
10.1016/j.bmc.2008.07.005 |
| Homo sapiens |
SH-SY5Y |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SK-N-MC |
Activity |
nan |
None |
10.1038/nchembio.79 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
6000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
64.8 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
37.85 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
14963.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
25459.6 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
28566.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
29855.4 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
Voltage-gated calcium channel |
IC50 |
14000.0 |
nM |
10.1016/j.ejmech.2018.12.003 |
| Homo sapiens |
Voltage-gated calcium channel |
Inhibition |
25.0 |
% |
10.1016/j.ejmech.2018.12.003 |
| Homo sapiens |
Voltage-gated L-type calcium channel |
Inhibition |
45.5 |
% |
10.1021/jm801292b |
| Homo sapiens |
Voltage-gated L-type calcium channel |
Inhibition |
49.62 |
% |
10.1016/j.ejmech.2018.06.044 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
420.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
IC50 |
110.0 |
nM |
10.1002/jat.2784 |
| Homo sapiens |
Whole blood |
Retention_time |
7.14 |
min |
10.1007/s00044-012-9977-1 |
| Influenza A virus |
Nonstructural protein 1 |
Potency |
39810.7 |
nM |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
1.9 |
% |
10.6019/CHEMBL4513141 |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
128160.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Leishmania braziliensis |
Leishmania braziliensis |
IC50 |
42800.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Leishmania chagasi |
Leishmania chagasi |
IC50 |
21620.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Leishmania chagasi |
Leishmania chagasi |
IC50 |
82680.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Leishmania major |
Leishmania major |
IC50 |
31040.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Macaca fascicularis |
Brain |
Fu |
0.009 |
None |
10.1124/dmd.111.038778 |
| Macaca mulatta |
LLC-MK2 |
IC50 |
96190.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Mus musculus |
Brain |
Fu |
0.007 |
None |
10.1124/dmd.111.038778 |
| Mus musculus |
HT-22 |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00654 |
| Mus musculus |
Indoleamine 2,3-dioxygenase 2 |
Inhibition |
55.0 |
% |
10.1016/j.bmcl.2012.10.010 |
| Mus musculus |
Mus musculus |
No. of animals protected / no animals tested |
0.0 |
100mg kg-1 |
10.1021/jm960531r |
| Mus musculus |
Mus musculus |
No. of animals protected / no animals tested |
0.0 |
300mg kg-1 |
10.1021/jm960531r |
| Mus musculus |
Mus musculus |
No. of animals protected / no animals tested |
1.0 |
100mg kg-1 |
10.1021/jm960531r |
| Mus musculus |
Mus musculus |
No. of animals protected / no animals tested |
1.0 |
300mg kg-1 |
10.1021/jm960531r |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
P-glycoprotein 3 |
Activity |
nan |
None |
10.1016/0006-2952(92)90149-d |
| Mus musculus |
Transient receptor potential cation channel subfamily A member 1 |
EC50 |
800.0 |
nM |
10.1021/jm100062h |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
ID50 |
2e-10 |
M |
10.1021/jm00360a001 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
ID50 |
3e-10 |
M |
10.1021/jm00360a001 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
ID50 |
7e-10 |
M |
10.1021/jm00360a001 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
ID50 |
0.0001 |
M |
10.1021/jm00360a001 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
5011.87 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
7943.28 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
10000.0 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
12589.25 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1016/j.bmcl.2016.01.052 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
13459.1 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
14715.7 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
18526.0 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
19.21 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
20100.0 |
nM |
10.1021/jm9600205 |
| Rattus norvegicus |
Adenosine A2a receptor |
Ki |
44300.0 |
nM |
10.1021/jm9600205 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Brain |
Fu |
0.009 |
None |
10.1124/dmd.111.038778 |
| Rattus norvegicus |
Brain |
Fu |
0.01 |
None |
10.1124/dmd.111.038778 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Inhibition |
nan |
% |
10.1016/j.ejmech.2014.04.039 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Liver |
IC50 |
100.0 |
nM |
10.1002/hep.27206 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
10.1016/j.bmc.2011.05.034 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
PC-12 |
Activity |
nan |
None |
10.1021/acs.jnatprod.7b00690 |
| Rattus norvegicus |
PC-12 |
Activity |
nan |
None |
10.1038/nchembio.79 |
| Rattus norvegicus |
PC-12 |
EC50 |
1.29 |
ug.mL-1 |
10.1021/acs.jnatprod.9b00351 |
| Rattus norvegicus |
PC-12 |
EC50 |
97300.0 |
nM |
10.1021/acs.jnatprod.7b01076 |
| Rattus norvegicus |
PC-12 |
Survival |
90.4 |
% |
10.1016/j.bmcl.2015.04.013 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
16136.6 |
nM |
None |
| Rattus norvegicus |
Plasma |
Fu |
0.016 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Plasma |
logFu |
0.05 |
None |
10.1016/j.ejmech.2009.06.004 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
26.8 |
% |
10.1016/j.ejmech.2020.113030 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.bmcl.2016.04.031 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
38700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
39700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
40000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41200.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
160.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
389.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
425.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
427.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
445.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
464.83 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
59.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
64.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
65.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
72.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
77.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
90.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
82.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
88.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
88.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
89.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
89.83 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
102.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
3.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
4.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
120.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
121.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
130.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
141.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
150.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
436.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
84.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
97.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
98.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
99.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
100.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
100.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
553.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
630.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
696.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
750.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
751.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
776.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
248.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
283.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
287.17 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
367.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
468.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
716.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
30500000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
31670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
33000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
34170000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
34330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.6 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.2 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1426.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1453.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1533.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1628.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1986.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
2116.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
33.27 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.03 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
36.22 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
36.23 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
37.2 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
42.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
130300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
132700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
138500.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
139000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
147700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
168700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Kd |
690.0 |
nM |
10.1021/jm00107a001 |
| Rattus norvegicus |
Rattus norvegicus |
Kd' |
1.1e-10 |
M |
10.1021/jm00107a001 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
111.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
135.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
139.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
180.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
194.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
205.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
11.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
12.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
5312.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
8295.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
8640.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
9244.83 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
10257.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
13499.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
75.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
88.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
90.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
91.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
92.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
92.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.43 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.77 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.13 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.4 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.48 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.83 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
382500.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
383700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
390300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
392000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
393300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
397000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
59.63 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
59.87 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.75 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.08 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.37 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.63 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
34.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
84.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
96.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
102.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
159.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
2.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
6.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
7.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
8.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
9.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
10.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
22.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
859.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
869.83 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
970.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
975.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1037.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1728.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
99.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
102.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
103.2 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
104.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
108.5 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
110.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
883830.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
940000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
989000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1138000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1341670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1410000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
3.85 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
4.32 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.13 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.95 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.2 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.38 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
55700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
57700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
59000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
62000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
63300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5250000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5430000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5700000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5740000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
6210000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
7190000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.17 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.33 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
133.83 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
139.8 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.1 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.2 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.93 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
144.23 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
3.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
4.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
7.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
7.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
8.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
7200.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
9350.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
9500.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
10220.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
11270.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14630.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
11220.2 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
15848.9 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
19952.6 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
21192.3 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
18.3 |
nM |
10.1038/s41467-023-40064-9 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
IZ |
0.0 |
mm |
10.1016/j.ejmech.2010.07.050 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
20596.2 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.09541 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.4876 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
7.57 |
% |
10.6019/CHEMBL4513141 |
| Trypanosoma cruzi |
Cruzipain |
Potency |
39810.7 |
nM |
None |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
32310.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.bmc.2010.09.015 |
| None |
ADMET |
CL |
14.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
15.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
CL |
33.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
34.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
56.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
delta logD |
0.0 |
None |
10.1021/jm0000564 |
| None |
ADMET |
F |
20.0 |
% |
10.1021/jm0000564 |
| None |
ADMET |
Fu |
0.007 |
None |
10.1124/dmd.111.038778 |
| None |
ADMET |
MRT |
1.2 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Partition coefficient |
6300.0 |
None |
10.1021/jm00107a001 |
| None |
ADMET |
PPB |
98.17 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
PPB |
98.25 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
PPB |
98.84 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
T1/2 |
1.3 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.9 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
0.96 |
mL/min/kg |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
1.1 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
3.2 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
3.6 |
L.kg-1 |
10.1002/jps.20373 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
17.6 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
5.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
17.6 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
2.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
23.4 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
23.4 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
29.3 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Molecular identity unknown |
Activity |
nan |
None |
10.1016/j.ejmech.2014.04.039 |
| None |
NON-PROTEIN TARGET |
Anticonvulsant activity |
nan |
None |
10.1016/s0960-894x(03)00535-3 |
| None |
NON-PROTEIN TARGET |
Fu |
0.008 |
None |
10.1124/dmd.111.038778 |
| None |
NON-PROTEIN TARGET |
Fu |
0.016 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.7 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
2.7 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
5.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Potency |
4466.8 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
6309.6 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
7943.3 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
8912.5 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
10000.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
12589.3 |
nM |
None |
| None |
No relevant target |
Kp |
187.0 |
None |
10.1021/jm960531r |
| None |
No relevant target |
LogD |
0.73 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
LogD7.4 |
3.8 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Log Kmemb |
2.4 |
None |
10.1021/jm0309001 |
| None |
No relevant target |
LogP |
4.2 |
None |
10.1021/acs.jmedchem.5b00201 |
| None |
No relevant target |
-log(solubility) |
4.97 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
5.0 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
5.02 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
5.24 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
5.32 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
5.39 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
6.4 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
6.62 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
Partition coefficient |
730.0 |
None |
10.1021/jm00107a001 |
| None |
No relevant target |
pKa |
nan |
None |
10.1021/jm0000564 |
| None |
No relevant target |
Solubility |
3100.0 |
nM |
10.6019/CHEMBL3301361 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Ac50 |
1.778 |
uM |
None |
| None |
Unchecked |
AC50 |
1778.3 |
nM |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2010.07.050 |
| None |
Unchecked |
EC50 |
520.0 |
nM |
10.1016/j.bmc.2017.07.002 |
| None |
Unchecked |
Hepatotoxicity (acute) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
0.242 |
nM |
None |
| None |
Unchecked |
IC50 |
2.093 |
nM |
None |
| None |
Unchecked |
IC50 |
8.0 |
nM |
10.1016/j.bmcl.2016.01.052 |
| None |
Unchecked |
IC50 |
1266.0 |
nM |
None |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
12.29 |
% |
10.1016/j.bmc.2011.05.034 |
| None |
Unchecked |
Inhibition |
12.29 |
% |
10.1016/j.ejmech.2011.08.008 |
| None |
Unchecked |
Inhibition |
34.07 |
% |
10.1016/j.ejmech.2020.112617 |
| None |
Unchecked |
Inhibition |
45.5 |
% |
10.1021/jm061047j |
| None |
Unchecked |
Inhibition |
48.0 |
% |
10.1016/j.bmcl.2021.128160 |
| None |
Unchecked |
Inhibition |
100.0 |
% |
10.1016/j.ejmech.2014.04.039 |
| None |
Unchecked |
Inhibition |
100.0 |
% |
10.1039/C4MD00244J |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.bmc.2011.05.034 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2011.08.008 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2014.04.039 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2020.112617 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1039/C4MD00244J |
| None |
Unchecked |
Ki |
0.156 |
nM |
None |
| None |
Unchecked |
Ki |
1.86 |
nM |
None |
| None |
Unchecked |
Ki |
433.0 |
nM |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
316.2 |
nM |
None |
| None |
Unchecked |
Potency |
1158.2 |
nM |
None |
| None |
Unchecked |
Potency |
2059.6 |
nM |
None |
| None |
Unchecked |
Potency |
5011.9 |
nM |
None |
| None |
Unchecked |
Potency |
5623.4 |
nM |
None |
| None |
Unchecked |
Potency |
9200.0 |
nM |
None |
| None |
Unchecked |
Potency |
14125.4 |
nM |
None |
| None |
Unchecked |
Potency |
35481.3 |
nM |
None |
| None |
Unchecked |
Ratio IC50 |
5.8 |
None |
10.1021/acs.jmedchem.2c00458 |
| None |
Unchecked |
Ratio IC50 |
20.0 |
None |
10.1016/j.bmc.2010.03.038 |
| None |
Unchecked |
Ratio IC50 |
nan |
None |
10.1016/j.bmcl.2016.01.052 |
| None |
Unchecked |
Selectivity Index |
2.98 |
None |
10.1016/j.bmc.2010.09.015 |
| None |
Unchecked |
Selectivity Index |
4.45 |
None |
10.1016/j.bmc.2010.09.015 |